Background: Early detection of pancreatic ductal adenocarcinoma (PDAC) is critical. While faecal elastase-1 (FE-1) is a standard clinical marker for pancreatic function, its diagnostic accuracy for malignancy is limited. We sought to identify plasma metabolites that enhance FE-1 performance in symptomatic “at-risk” patients.
Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma
calendar_today
July 19, 2026
person
Niazi, U., Roberts, C. A., McDonnell, D., Goss, V. M., Afolabi, P. R., Swann, J. R., Byrne, C. D., Griffiths, G. O., Hamady, Z. Z.
domain
medrxiv